Connection

Paolo Maggi to HIV Infections

Back to Details
This is a "connection" page, showing publications Paolo Maggi has written about HIV Infections.
Paolo Maggi
Connection Strength
0.940
HIV Infections
  1. Dangerous liaisons? The role of inflammation and comorbidities in HIV and SARS-CoV-2 infection. Expert Rev Clin Immunol. 2021 03; 17(3):201-208.
    View in: PubMed
    Score: 0.142
  2. Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study. BMC Infect Dis. 2019 Jun 25; 19(1):555.
    View in: PubMed
    Score: 0.127
  3. Cardiovascular risk and dyslipidemia among persons living with HIV: a review. BMC Infect Dis. 2017 08 09; 17(1):551.
    View in: PubMed
    Score: 0.112
  4. Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort. Atherosclerosis. 2017 08; 263:398-404.
    View in: PubMed
    Score: 0.110
  5. Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians. New Microbiol. 2017 Apr; 40(2):139-142.
    View in: PubMed
    Score: 0.107
  6. Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients. In Vivo. 2017 01 02; 31(1):125-131.
    View in: PubMed
    Score: 0.107
  7. Factors associated with hospital admission for COVID-19 in HIV patients. AIDS. 2020 11 01; 34(13):1983-1985.
    View in: PubMed
    Score: 0.035
  8. SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients. New Microbiol. 2019 Jul; 42(3):150-155.
    View in: PubMed
    Score: 0.032
  9. Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA). BMC Infect Dis. 2018 07 31; 18(1):357.
    View in: PubMed
    Score: 0.030
  10. A Comprehensive Development Agenda on Tenofovir Alafenamide in Clinical Practice. AIDS Rev. 2018 Apr-Jun; 20(2):75-82.
    View in: PubMed
    Score: 0.029
  11. Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience. J Women Aging. 2019 Mar-Apr; 31(2):176-188.
    View in: PubMed
    Score: 0.029
  12. Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project. PLoS One. 2017; 12(6):e0179254.
    View in: PubMed
    Score: 0.028
  13. Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study. J Hypertens. 2017 02; 35(2):409-416.
    View in: PubMed
    Score: 0.027
  14. Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir. AIDS. 2017 01 28; 31(3):455-457.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.